COMPANY PROFILE · UPDATED 18 NOV 2025

Initial Therapeutics

Initial Therapeutics is an ATP company that develops small-molecule medicines designed to prevent pathogenic protein synthesis. The company provides an approach that is differentiated from protein degradation and other interventions that…

initialtx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2020
Headcount: 20
Open roles: 0
Last raised: Series A · Sign in to view

LEADERSHIP

Founders & key people

Kevan Shokat

Founder at Mitokinin

Rezo TherapeuticseFFECTOR TherapeuticsRevolution MedicinesMitokininHoward Hughes Medical InstituteGenentechUniversity of California BerkeleyHaas School of Business

Spiros Liras

CEO at Deep Apple Therapeutics

Nereid TherapeuticsNine Square TherapeuticsDeep Apple TherapeuticsUCSFBiogenApple Tree PartnersThe University of Texas at AustinIowa State University

Brian Paegel

Researcher ORCID ID = 0000-0002-6531-6693

The Scripps Research InstituteUniversity of California IrvineUniversity of California BerkeleyUniversity of CaliforniaUniversity of CaliforniaDuke University

Jamie Cate

Founder at Sugarlogix

Sugarlogix

OPEN ROLES

Roles at Initial Therapeutics

Employbl doesn’t track Initial Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING